A balanced review of the status T cell-based therapy against cancer

<p>Abstract</p> <p>A recent commentary stirred intense controversy over the status of anti-cancer immunotherapy. The commentary suggested moving beyond current anti-cancer vaccines since active-specific immunization failed to match expectations toward a more aggressive approach inv...

Full description

Bibliographic Details
Main Author: Marincola Francesco M
Format: Article
Language:English
Published: BMC 2005-04-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/3/1/16
id doaj-00948f2efc1948e5a5849f4f3a7cd2d0
record_format Article
spelling doaj-00948f2efc1948e5a5849f4f3a7cd2d02020-11-24T21:40:18ZengBMCJournal of Translational Medicine1479-58762005-04-01311610.1186/1479-5876-3-16A balanced review of the status T cell-based therapy against cancerMarincola Francesco M<p>Abstract</p> <p>A recent commentary stirred intense controversy over the status of anti-cancer immunotherapy. The commentary suggested moving beyond current anti-cancer vaccines since active-specific immunization failed to match expectations toward a more aggressive approach involving the adoptive transfer of in vitro expanded tumor antigen-specific T cells. Although the same authors clarified their position in response to others' rebuttal more discussion needs to be devoted to the current status of T cell-based anti-cancer therapy. The accompanying publications review the status of adoptive transfer of cancer vaccines on one hand and active-specific immunization on the other. Hopefully, reading these articles will offer a balanced view of the current status of antigen-specific ant-cancer therapies and suggest future strategies to foster unified efforts to complement either approach with the other according to specific biological principles.</p> http://www.translational-medicine.com/content/3/1/16
collection DOAJ
language English
format Article
sources DOAJ
author Marincola Francesco M
spellingShingle Marincola Francesco M
A balanced review of the status T cell-based therapy against cancer
Journal of Translational Medicine
author_facet Marincola Francesco M
author_sort Marincola Francesco M
title A balanced review of the status T cell-based therapy against cancer
title_short A balanced review of the status T cell-based therapy against cancer
title_full A balanced review of the status T cell-based therapy against cancer
title_fullStr A balanced review of the status T cell-based therapy against cancer
title_full_unstemmed A balanced review of the status T cell-based therapy against cancer
title_sort balanced review of the status t cell-based therapy against cancer
publisher BMC
series Journal of Translational Medicine
issn 1479-5876
publishDate 2005-04-01
description <p>Abstract</p> <p>A recent commentary stirred intense controversy over the status of anti-cancer immunotherapy. The commentary suggested moving beyond current anti-cancer vaccines since active-specific immunization failed to match expectations toward a more aggressive approach involving the adoptive transfer of in vitro expanded tumor antigen-specific T cells. Although the same authors clarified their position in response to others' rebuttal more discussion needs to be devoted to the current status of T cell-based anti-cancer therapy. The accompanying publications review the status of adoptive transfer of cancer vaccines on one hand and active-specific immunization on the other. Hopefully, reading these articles will offer a balanced view of the current status of antigen-specific ant-cancer therapies and suggest future strategies to foster unified efforts to complement either approach with the other according to specific biological principles.</p>
url http://www.translational-medicine.com/content/3/1/16
work_keys_str_mv AT marincolafrancescom abalancedreviewofthestatustcellbasedtherapyagainstcancer
AT marincolafrancescom balancedreviewofthestatustcellbasedtherapyagainstcancer
_version_ 1725926813377495040